Cargando…
In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer
Background: While immunotherapy moved to the forefront of treatment of various cancers, it remains underexplored for uterine cancer. This might be due to the small patient population with advanced endometrial carcinoma and uterine sarcoma. Data about immunotherapeutic targets are scarce in endometri...
Autores principales: | Vanderstraeten, Anke, Tuyaerts, Sandra, Everaert, Tina, Van Bree, Rieta, Verbist, Godelieve, Luyten, Cathérine, Amant, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037800/ https://www.ncbi.nlm.nih.gov/pubmed/27618037 http://dx.doi.org/10.3390/ijms17091525 |
Ejemplares similares
-
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
por: Vanderstraeten, Anke, et al.
Publicado: (2014) -
BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells
por: Renaud, Stéphanie, et al.
Publicado: (2011) -
High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
por: Alberti, Loredana, et al.
Publicado: (2014) -
Potential Therapeutic Targets in Uterine Sarcomas
por: Cuppens, Tine, et al.
Publicado: (2015) -
In silico Analysis of Human Telomerase Reverse Transcriptase (hTERT) Gene: Identification of a Distant Homolog of Melanoma Antigen Family Gene (MAGE)
por: Amin, Ruhul, et al.
Publicado: (2009)